Bernstein maintains $101 target on McCormick stock, cites reformulation trend

Published 27/03/2025, 15:00
Bernstein maintains $101 target on McCormick stock, cites reformulation trend

On Thursday, Bernstein analysts reiterated their positive stance on McCormick & Company (NYSE:MKC) shares, maintaining an Outperform rating and a $101.00 price target. The firm’s outlook is based on the anticipation of a reformulation supercycle in the U.S. packaged foods industry, which they believe could significantly benefit McCormick and other flavor companies.

McCormick management, during the first quarter 2025 earnings call on Tuesday, acknowledged an uptick in activity around product reformulation. This development comes in the wake of RFK Jr.’s advocacy for the removal of artificial colors, preservatives, and other additives from packaged foods in the United States. The company also noted potential efforts to reduce sodium and added sugar levels. With a 39-year track record of consecutive dividend increases and a current yield of 2.23%, McCormick demonstrates strong shareholder returns amid industry changes.

Bernstein analysts draw parallels to a similar trend about 15 years ago when consumer concerns about artificial ingredients led to widespread changes in food formulations. They suggest that the industry may be at the beginning of another such cycle, spurred by recent and sudden attention to these issues.

The analyst’s comments highlight the potential for McCormick to capitalize on this shift as manufacturers look to adapt their products to meet changing consumer preferences and regulatory pressures.

McCormick’s stock price target of $101.00 by Bernstein reflects confidence in the company’s ability to navigate and benefit from the anticipated reforms in the industry. The company’s recent acknowledgment of increased reformulation activity aligns with Bernstein’s thesis of an emerging supercycle that could drive growth for flavor companies.

In other recent news, McCormick & Company reported mixed results for the first quarter of 2025, with a 2% increase in organic sales and a 20 basis point expansion in gross margin. Despite this, earnings per share fell short of some analysts’ estimates. Argus downgraded McCormick’s stock from "Buy" to "Hold," citing concerns over rising input costs and increased brand marketing spending, which may constrain earnings growth. Meanwhile, Bernstein raised its price target for McCormick to $101, maintaining an "Outperform" rating, as they anticipate improved profit growth in the upcoming quarter. TD Cowen adjusted their price target to $90 while keeping a "Buy" rating, highlighting robust volume growth despite earnings falling short of expectations. Stifel reaffirmed their "Hold" rating with an $82 price target, noting McCormick’s solid revenue growth and profitability. Additionally, McCormick’s CEO, Brendan Foley, acknowledged an increase in reformulation efforts among customers, aligning with industry trends toward healthier options. These developments reflect McCormick’s ongoing efforts to navigate market challenges and adapt to evolving consumer preferences.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.